JP2025529317A5 - - Google Patents
Info
- Publication number
- JP2025529317A5 JP2025529317A5 JP2025513674A JP2025513674A JP2025529317A5 JP 2025529317 A5 JP2025529317 A5 JP 2025529317A5 JP 2025513674 A JP2025513674 A JP 2025513674A JP 2025513674 A JP2025513674 A JP 2025513674A JP 2025529317 A5 JP2025529317 A5 JP 2025529317A5
- Authority
- JP
- Japan
- Prior art keywords
- patients weighing
- day
- composition according
- dose
- patients
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263404061P | 2022-09-06 | 2022-09-06 | |
| US63/404,061 | 2022-09-06 | ||
| US202363440984P | 2023-01-25 | 2023-01-25 | |
| US63/440,984 | 2023-01-25 | ||
| PCT/US2023/031836 WO2024054408A1 (en) | 2022-09-06 | 2023-09-01 | Supplemental dosage and administration of anti-c5 antibodies for treating hematopoietic stem cell transplant-associated thrombotic microangiopathy (hsct-tma) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025529317A JP2025529317A (ja) | 2025-09-04 |
| JP2025529317A5 true JP2025529317A5 (enExample) | 2026-05-18 |
Family
ID=88192212
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025513674A Pending JP2025529317A (ja) | 2022-09-06 | 2023-09-01 | 造血幹細胞移植関連血栓性微小血管症（ｈｓｃｔ－ｔｍａ）を治療するための抗ｃ５抗体の補足的投薬及び投与 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP4583910A1 (enExample) |
| JP (1) | JP2025529317A (enExample) |
| KR (1) | KR20250060282A (enExample) |
| CN (1) | CN120076827A (enExample) |
| AU (1) | AU2023338677A1 (enExample) |
| CA (1) | CA3266974A1 (enExample) |
| IL (1) | IL319413A (enExample) |
| TW (1) | TW202426048A (enExample) |
| WO (1) | WO2024054408A1 (enExample) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8367805B2 (en) | 2004-11-12 | 2013-02-05 | Xencor, Inc. | Fc variants with altered binding to FcRn |
| PY09026846A (es) | 2008-08-05 | 2015-09-01 | Novartis Ag | Composiciones y métodos para anticuerpos que se dirigen a la proteína de complemento c5 |
| ES2796078T3 (es) * | 2013-09-16 | 2020-11-25 | Childrens Hospital Med Ct | Composiciones y métodos para el tratamiento de la microangiopatía trombótica asociada al hsct |
| NZ711451A (en) | 2014-03-07 | 2016-05-27 | Alexion Pharma Inc | Anti-c5 antibodies having improved pharmacokinetics |
| EA201791366A1 (ru) | 2014-12-19 | 2018-02-28 | Чугаи Сейяку Кабусики Кайся | Антитела к c5 и способы их применения |
| WO2016200627A1 (en) * | 2015-06-09 | 2016-12-15 | Children's Hospital Medical Center | Dosing algorithm for complement inhibitor |
| TW201718014A (zh) * | 2015-10-12 | 2017-06-01 | 諾華公司 | C5抑制劑於移植相關微血管病之用途 |
| IL263481B2 (en) | 2016-06-14 | 2024-06-01 | Regeneron Pharma | Anti-c5 antibodies and uses thereof |
| JP2023503776A (ja) * | 2019-09-27 | 2023-02-01 | ヴォリューション イミュノ ファーマシューティカルズ エスエイ | 造血幹細胞移植後の血栓性微小血管症（ｈｓｃｔ－ｔｍａ）の治療方法 |
| JP7821160B2 (ja) | 2020-08-13 | 2026-02-26 | アレクシオン ファーマシューティカルズ， インコーポレイテッド | 造血幹細胞移植関連血栓性微小血管症（ｈｓｃｔ－ｔｍａ）を処置するための抗ｃ５抗体の用量及び投与 |
| CA3173016A1 (en) * | 2021-01-22 | 2022-07-28 | Gin-Fu CHEN | Methods of treating complement mediated thrombotic microangiopathy using an anti-c5 antibody |
-
2023
- 2023-08-30 TW TW112132717A patent/TW202426048A/zh unknown
- 2023-09-01 CN CN202380071841.9A patent/CN120076827A/zh active Pending
- 2023-09-01 JP JP2025513674A patent/JP2025529317A/ja active Pending
- 2023-09-01 CA CA3266974A patent/CA3266974A1/en active Pending
- 2023-09-01 WO PCT/US2023/031836 patent/WO2024054408A1/en not_active Ceased
- 2023-09-01 EP EP23776777.7A patent/EP4583910A1/en active Pending
- 2023-09-01 AU AU2023338677A patent/AU2023338677A1/en active Pending
- 2023-09-01 IL IL319413A patent/IL319413A/en unknown
- 2023-09-01 KR KR1020257011087A patent/KR20250060282A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7101621B2 (ja) | 単一ドメイン血清アルブミン結合タンパク質 | |
| AU2009227872B2 (en) | Method and system to remove soluble TNFR1, TNFR2, and IL2 in patients | |
| JP2021526534A5 (enExample) | ||
| JP2021501134A5 (enExample) | ||
| JP2020528894A5 (enExample) | ||
| JP6460993B2 (ja) | 血管疾患及びその合併症の処置 | |
| JP2021525718A5 (enExample) | ||
| EA014025B1 (ru) | Композиции антитела против cd3 | |
| KR20140123475A (ko) | 항체 제형 및 방법 | |
| JP2023533030A5 (enExample) | ||
| JPS601135A (ja) | 免疫グロブリン−ｇ−含有フラクシヨン | |
| JP2023539047A5 (enExample) | ||
| JP2020535151A (ja) | 病気の症状の治療又は予防に使用するための抗アドレノメデュリン（ａｄｍ）バインダー | |
| JP2024540480A5 (enExample) | ||
| CN115768789A (zh) | 用于获得包含人血浆来源的免疫球蛋白m的组合物的方法 | |
| US20230173155A1 (en) | Dialysis system for treating sepsis | |
| JP6942356B2 (ja) | 制御性ｔ細胞の活性化剤及びその使用 | |
| KR20230142834A (ko) | 항-cd38 항체 및 이의 용도 | |
| CN118146377B (zh) | 靶向pear1受体的抗血小板聚集的抗体及其制备方法和应用 | |
| JP2023550310A5 (enExample) | ||
| JP2023507852A5 (enExample) | ||
| TWI886758B (zh) | 抗pvrig/抗tigit雙特異性抗體在治療惡性腫瘤中的用途 | |
| RU2024117500A (ru) | Дозы и введение антител против c5 для лечения атипичного гемолитико-уремического синдрома (агус) | |
| RU2021125057A (ru) | ДОЗЫ И ВВЕДЕНИЕ АНТИТЕЛ ПРОТИВ C5 ДЛЯ ЛЕЧЕНИЯ АТИПИЧНОГО ГЕМОЛИТИКО-УРЕМИЧЕСКОГО СИНДРОМА (аГУС) | |
| CN121846263A (zh) | Bcma-cd19双特异性car-免疫细胞在治疗淀粉样变性中的应用 |